HK1087357A1 - Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder. - Google Patents

Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.

Info

Publication number
HK1087357A1
HK1087357A1 HK06109619.6A HK06109619A HK1087357A1 HK 1087357 A1 HK1087357 A1 HK 1087357A1 HK 06109619 A HK06109619 A HK 06109619A HK 1087357 A1 HK1087357 A1 HK 1087357A1
Authority
HK
Hong Kong
Prior art keywords
estra
benzodioxol
dien
propynyl
hydroxy
Prior art date
Application number
HK06109619.6A
Other languages
English (en)
Inventor
Cornelis Sennef
B W M M Bernardus Peeters
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1087357A1 publication Critical patent/HK1087357A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06109619.6A 2001-10-26 2006-08-29 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder. HK1087357A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26

Publications (1)

Publication Number Publication Date
HK1087357A1 true HK1087357A1 (en) 2006-10-13

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06109619.6A HK1087357A1 (en) 2001-10-26 2006-08-29 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.

Country Status (27)

Country Link
US (1) US20040266863A1 (ko)
EP (2) EP1441739B1 (ko)
JP (1) JP4647909B2 (ko)
KR (1) KR20050038580A (ko)
CN (1) CN100531738C (ko)
AT (2) ATE420649T1 (ko)
AU (1) AU2002348996B2 (ko)
BR (1) BR0213466A (ko)
CA (1) CA2463446C (ko)
CY (1) CY1110173T1 (ko)
DE (2) DE60209248D1 (ko)
DK (1) DK1652526T3 (ko)
EC (1) ECSP045080A (ko)
ES (1) ES2319563T3 (ko)
HK (1) HK1087357A1 (ko)
HR (1) HRP20040370B1 (ko)
HU (1) HUP0500070A3 (ko)
IL (2) IL161248A0 (ko)
IS (1) IS2702B (ko)
MX (1) MXPA04003781A (ko)
NO (1) NO332978B1 (ko)
NZ (1) NZ532429A (ko)
PL (1) PL206687B1 (ko)
PT (1) PT1652526E (ko)
RU (1) RU2302245C2 (ko)
WO (1) WO2003037354A1 (ko)
ZA (1) ZA200403088B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
US20080255074A1 (en) * 2004-11-19 2008-10-16 N.V. Organon Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression
CA2649894A1 (en) * 2006-05-02 2007-11-15 Corcept Therapeutics, Inc. The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
JP5804395B2 (ja) * 2011-02-03 2015-11-04 ポップ テスト オンコロジー エルエルシー 診断と治療のためのシステムおよび方法
WO2012145258A1 (en) * 2011-04-18 2012-10-26 Pop Test Cortisol Llc Hair loss treatment
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
JP2001518509A (ja) * 1997-10-06 2001-10-16 ザ ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ グルココルチコイド関連機能不全に関連した精神病の処置のための方法。
CA2440605C (en) * 2001-03-23 2012-01-10 Corcept Therapeutics, Inc. Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
NZ529456A (en) * 2001-05-04 2005-10-28 Corcept Therapeutics Inc Use of GR antagonists such as RU009 and RU044 to ameliorate the symptoms of delirium
ES2314103T3 (es) * 2001-08-31 2009-03-16 Corcept Therapeutics, Inc. Metodo para inhibir deterioro cognitivo en adultos con sindrome de down.

Also Published As

Publication number Publication date
ATE420649T1 (de) 2009-01-15
EP1652526B1 (en) 2009-01-14
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
EP1652526A2 (en) 2006-05-03
JP2005521637A (ja) 2005-07-21
IL161248A0 (en) 2004-09-27
US20040266863A1 (en) 2004-12-30
MXPA04003781A (es) 2004-07-30
KR20050038580A (ko) 2005-04-27
BR0213466A (pt) 2004-11-09
IS7204A (is) 2004-03-31
CA2463446A1 (en) 2003-05-08
HUP0500070A3 (en) 2012-09-28
ECSP045080A (es) 2004-06-28
CA2463446C (en) 2010-02-23
IL161248A (en) 2010-12-30
DE60230936D1 (de) 2009-03-05
HRP20040370A2 (en) 2004-08-31
NZ532429A (en) 2004-10-29
PL206687B1 (pl) 2010-09-30
ES2319563T3 (es) 2009-05-08
JP4647909B2 (ja) 2011-03-09
DE60209248D1 (de) 2006-04-20
PL369261A1 (en) 2005-04-18
EP1441739A1 (en) 2004-08-04
ATE317700T1 (de) 2006-03-15
ZA200403088B (en) 2005-01-24
EP1441739B1 (en) 2006-02-15
WO2003037354A1 (en) 2003-05-08
IS2702B (is) 2010-11-15
PT1652526E (pt) 2009-02-06
NO332978B1 (no) 2013-02-11
HUP0500070A2 (hu) 2005-04-28
CN1582153A (zh) 2005-02-16
AU2002348996B2 (en) 2008-06-05
CN100531738C (zh) 2009-08-26
CY1110173T1 (el) 2015-01-14
HRP20040370B1 (en) 2012-09-30
DK1652526T3 (da) 2009-05-18
EP1652526A3 (en) 2006-08-02
RU2004116082A (ru) 2005-05-10

Similar Documents

Publication Publication Date Title
HK1087357A1 (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.
UA83620C2 (ru) Замещенные бензоксазолы и их аналоги как эстрогенные агенты
CY1104981T1 (el) Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων
PL345955A1 (en) PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
SG153645A1 (en) Hormone replacement therapy
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
IL159714A (en) Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
IL133632A (en) Use of a specific 5ht2 receptor antagonist for the preparation of pharmaceutical compositions useful in the treatment of the sleep apnea syndrome
MXPA01008993A (es) Tratamiento de combinacion para depresion y ansiedad.
WO2002074315A8 (de) Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
EA200501739A1 (ru) Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний
RS50350B (sr) Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma
HK1070900A1 (en) Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
YU30103A (sh) Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
NO20022712D0 (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene
BR0304292A (pt) Preparado de combinação de estrogênio-gestagênio e uso

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131021